Stimulation of adenosine receptors selectively activates gene expression in striatal enkephalinergic neurons

Neuropsychopharmacology

Volumn 31, Issue 10, 2006, Pages 2173-2179

  Karcz Kubicha, Marzena ^a,b   Ferré, Sergi ^a   Díaz Ruiz, Oscar ^a   Quiroz Molina, César ^a   Goldberg, Steven R ^a   Hope, Bruce T ^a   Morales, Marisela ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Johns Hopkins University   (United States)

Author keywords

Adenosine A1 receptor; Adenosine A2A receptor; c Fos; Dynorphin; Enkephalin; Striatum

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE RECEPTOR; DOPAMINE 2 RECEPTOR; DYNORPHIN; ENKEPHALIN; PREPROENKEPHALIN; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GABAERGIC TRANSMISSION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOREACTIVITY; MALE; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; STIMULATION; STRIATE CORTEX;

ADENOSINE; ANIMALS; CORPUS STRIATUM; DRUG COMBINATIONS; ENKEPHALINS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEURONS; PHENETHYLAMINES; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1;

EID: 33748783064     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301035     Document Type: Article

References (41)

1. Agnati LF, Ferré S, Lluis C, Franco R, Fuxe K (2003). Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55: 509-550.
2. Aoyama S, Koga K, Mori A, Miyaji H, Sekine S, Kase H et al (2002). Distribution of adenosine A(2A) receptor antagonist KW-6002 and its effect on gene expression in the rat brain. Brain Res 953: 119-125.
3. Backman C, Hoffer BJ, Misawa H, Morales M (2001). Cellular mRNA expression of the transcription factor NGFI-B suggests a gene regulatory role in striatal opiate-peptide neurons. Brain Res 903: 26-32.
4. Borsook D, Hyman SE (1995). Proenkephalin gene regulation in the neuroendocrine hypothalamus: a model of gene regulation in the CNS. Am J Physiol 269: E393-E408.
5. Canals M, Marcellino M, Fanelli F, Ciruela F, de Benedetti P, Goldberg S et al (2003). Adenosine A2A-dopamine D2 receptor-receptor heteromerization. Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278: 46741-46749.
6. Carta AR, Pinna A, Cauli O, Morelli M (2002). Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats. Synapse 44: 166-174.
7. Chen JF, Moratalla R, Yu L, Martin AB, Xu K, Bastia E et al (2003). Inactivation of adenosine A2A receptors selectively attenuates amphetamine-induced behavioral sensitization. Neuropsychopharmacology 28: 1086-1095.
8. Chern Y (2000). Regulation of adenylyl cyclase in the central nervous system. Cell Signal 12: 195-204.
9. Ciruela F, Burgueno J, Casado V, Canals M, Marcellino D, Goldberg SR et al (2004). Combining nass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal Chem 76: 5354-5363.
10. Defer N, Best-Belpomme M, Hanoune J (2000). Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol Renal Physiol 279: F400-F416.
11. Ferré S, Ciruela F, Canals M, Marcellino D, Burgueno J, Casado V et al (2004). Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism Relat Disord 10: 265-271.
12. Ferré S, Ciruela F, Woods AS, Canals M, Burgueno J, Marcellino D et al (2003). Glutamate mGlu5-adenosine A2A-dopamine D2 receptor interactions in the striatum. Implications for drug therapy in neuro-psychiatric disorders and drug abuse. Curr Med Chem-Central Nerv Systems Agents 33: 1-26.
13. Ferré S, Fredholm BB, Morelli M, Popoli P, Fuxe K (1997). Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20: 482-487.
14. Ferré S, O'Connor WT, Fuxe K, Ungerstedt U (1993). The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J Neurosci 13: 5402-5406.
15. Ferré S, O'Connor WT, Svenningsson P, Bjorklund L, Lindberg J, Tinner B et al (1996). Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur J Neurosci 8: 1545-1553.
16. Ferré S, Rimondini R, Popoli P, Reggio R, Pezzola A, Hansson AC et al (1999). Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour. Eur J Neurosci 11: 3884-3892.
17. Ferré S, von Euler G, Johansson B, Fredholm BB, Fuxe K (1991). Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88: 7238-7241.
18. Gerfen CR (2000). Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci 23: S64-S70.
19. Gerfen CR (2004). Basal ganglia. In: Paxinos G (ed). The Rat Nervous System. Elsevier: San Diego. pp 455-508.
20. Greengard P, Allen PB, Nairn AC (1999). Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23: 435-447.
21. Herdegen T, Leah JD (1998). Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 28: 370-490.
22. Hettinger BD, Lee A, Linden J, Rosin DL (2001). Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol 43: 331-346.
23. Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A et al (2002). Coaggregation, cointernalisation, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277: 18091-18097.
24. Kamiya T, Saitoh O, Yoshioka K, Nakata H (2003). Oligomerization of adenosine A2A and dopamine D2 receptors in living cells. Biochem Biophys Res Commun 306: 544-549.
25. Karcz-Kubicha M, Quarta D, Hope BT, Antoniou K, Muller CE, Morales M et al (2003). Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos. Eur J Neurosci 18: 296-302.
26. Kudlacek O, Just H, Korkhov VM, Vartian N, Klinger M, Pankevych H et al (2003). The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells. Neuropsychopharmacology 28: 1317-1327.
27. Kull B, Ferré S, Arslan G, Svenningsson P, Fuxe K, Owman C et al (1999). Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochem Pharmacol 58: 1035-1045.
28. Kull B, Svenningsson P, Fredholm BB (2000). Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol Pharmacol 58: 771-777.
29. Lee KW, Hong JH, Choi IY, Che Y, Lee JK, Yang SD et al (2002). Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J Neurosci 22: 7931-7940.
30. Le Moine C, Svenningsson P, Fredholm BB, Bloch B (1997). Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression. J Neurosci 17: 8038-8048.
31. Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA et al (2002). Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418: 774-778.
32. Morales M, Criado JR, Sanna PP, Henriksen SJ, Bloom FE (1998). Acute ethanol induces c-Fos immunoreactivity in GABAergic neurons of the central nucleus of the amygdala. Brain Res 798: 333-336.
33. Pinna A, Wardas J, Cristalli G, Morelli M (1997). Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas. Brain Res 759: 41-49.
34. Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F et al (2004). Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. J Neurochem 91: 873-880.
35. Schiffmann SN, Jacobs O, Vanderhaeghen JJ (1991). Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57: 1062-1067.
36. Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G (1998). Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience 84: 223-228.
37. Uslaner J, Badiani A, Norton CS, Day HE, Watson SJ, Akil H et al (2001). Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 13: 1977-1983.
38. Vortherms TA, Watts VJ (2004). Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation. J Pharmacol Exp Ther 308: 221-227.
39. Wardas J, Pietraszek M, Dziedzicka-Wasylewska M (2003). SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum. Brain Res 977: 270-277.
40. Woods AS, Ferré S (2005). Amazing stability of the argininephosphate electrostatic interaction. J Proteome Res 4: 1397-1402.
41. Yao L, Arolfo MP, Dohrman DP, Jiang Z, Fan P, Fuchs S et al (2002). betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell 109: 733-743.